ClassID:

21647

A61K2300/00 - page 45 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#13201
20090318394
2009-12-24

Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same

#13202
20090318391
2009-12-24

Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent

#13203
20090318390
2009-12-24

Combinations comprising epothilones and pharmaceutical uses thereof

#13204
20090318388
2009-12-24

Method of activation of oxazaphosphorines

#13205
20090318384
2009-12-24

COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

#13206
20090318379
2009-12-24

Statins for the Treatment of Viral Influenza Infections

#13207
20090318378
2009-12-24

Antibiotic combinations for providing total solution to the treatment of infections

#13208
20090318345
2009-12-24

MEANS AND METHODS FOR MODULATING STEM CELL MOBILIZATION

#13209
20090318334
2009-12-24

Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease

#13210
20090318330
2009-12-24

Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take

#13211
20090317503
2009-12-24

Eyelid Preparation and Method of Use

#13212
20090317502
2009-12-24

DANDRUFF TREATMENT COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS INCLUDING BOTANIC SEED OILS

#13213
20090317497
2009-12-24

Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders

#13214
20090317495
2009-12-24

Composition comprising and extracts for the treatment and prevention of inflammatory diseases

#13215
20090317489
2009-12-24

Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof

#13216
20090317485
2009-12-24

Skin Protectant Spray Compositions

#13217
20090317484
2009-12-24

Salivary substitute

#13218
20090317482
2009-12-24

METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE

#13219
20090317477
2009-12-24

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A GLUCOCORTICOSTEROID FOR TREATMENT OF ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE OR ALLERGIC RHINITIS

#13220
20090317476
2009-12-24

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#13221
20090317475
2009-12-24

COMBINATION ANTITUMOR THERAPIES

#13222
20090317463
2009-12-24

COMPOSITION FOR ORAL USE BASED ON S-ADENOSYLMETHIONINE AND A PROCESS FOR THEIR PREPARATION

#13223
20090317459
2009-12-24

Water-insoluble, iron-containing mixed metal, granular material

#13224
20090317456
2009-12-24

USE OF ONCOLYTIC VIRUSES AND ANTIANGIOGENIC AGENTS IN THE TREATMENT OF CANCER

#13225
20090317455
2009-12-24

REVERSE TARGETING LIPID VESICLE

#13226
20090317439
2009-12-24

Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

#13227
20090317438
2009-12-24

Whole blood-derived coagulum device for treating bone defects

#13228
20090317435
2009-12-24

Methods for processing substrates having an antimicrobial coating

#13229
20090317388
2009-12-24

Tl1a in treatment of disease

#13230
20090317387
2009-12-24

TREATMENT OF METASTATIC BREAST CANCER

#13231
20090317385
2009-12-24

Methods using immunomodulatory compounds for modulating level of CD59

#13232
20090317384
2009-12-24

Methods of using death receptor ligands and cd20 antibodies

#13233
20090317383
2009-12-24

CANCER TREATMENT METHOD

#13234
20090317378
2009-12-24

Antimicrobial composition and uses thereof

#13235
20090317377
2009-12-24

Therapy procedure for drug delivery for trigeminal pain

#13236
20090317376
2009-12-24

Compositions And Methods For Lipo Modeling

#13237
20090317372
2009-12-24

SMALL MOLECULES FOR THE REDUCTION OF HIGH BLOOD GLUCOSE LEVEL

#13238
20090317371
2009-12-24

Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases

#13239
20090317364
2009-12-24

NOVEL COMPOSITIONS FOR PREVENTION AND TREATMENT OF MASTITIS AND METRITIS

#13240
20090317355
2009-12-24

ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION

#13241
20090317346
2009-12-24

Deodorant agent

#13242
20090312724
2009-12-17

Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions

#13243
20090312433
2009-12-17

TREATMENT OF VR1-ANTAGONIST-INDUCED INCREASE IN BODY TEMPERATURE WITH AN ANTIPYRETIC AGENT

#13244
20090312431
2009-12-17

Methods for eradicating lice and fleas from a host

#13245
20090312427
2009-12-17

Medicament for Use in Connection With Cartilage Impairment

#13246
20090312404
2009-12-17

Cleavable carnitine compound

#13247
20090312391
2009-12-17

Unifying mechanism and methods to prevent cancer and neurodegenerative diseases

#13248
20090312373
2009-12-17

METHODS FOR THE TREATMENT OF CANCER USING PIPERLONGUMINE AND PIPERLONGUMINE ANALOGS

#13249
20090312371
2009-12-17

Substituted arylpyrazoles

#13250
20090312367
2009-12-17

COMBINATION OF MODAFINIL AND AN ANTAGONIST OR INVERSE AGONIST OF THE H3 RECEPTOR

#13251
20090312361
2009-12-17

NOVEL PHARMACEUTICAL COMPOSITIONS FOR TREATING ACQUIRED CHRONIC PAIN AND ASSOCIATED DYSPHORIA

#13252
20090312360
2009-12-17

Antineoplastic Combinations Containing HKI-272 and Vinorelbine

#13253
20090312358
2009-12-17

METHOD FOR MANAGEMENT OF DIARRHEA

#13254
20090312350
2009-12-17

Compositions comprising balaglitazone and further antidiabetic compounds

#13255
20090312337
2009-12-17

Compositions containing alpha-2-adrenergic agonist components

#13256
20090312302
2009-12-17

Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders

#13257
20090312296
2009-12-17

ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES

#13258
20090312295
2009-12-17

Second line treatment of metastatic hormone refractory prostate cancer using satraplatin

#13259
20090312290
2009-12-17

Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia

#13260
20090312287
2009-12-17

Multi-carotenoids compositions and methods

#13261
20090312284
2009-12-17

HISTONE DEACETYLASE INHIBITORS WITH COMBINED ACTIVITY ON CLASS-I AND CLASS-IIB HISTONE DEACETYLASES IN COMBINATION WITH PROTEASOME INHIBITORS

#13262
20090312280
2009-12-17

COMBINATION THERAPY OF (2R,Z)-2-AMINO-2-CYCLOHEXYL-N-(5-(1-METHYL-1H-PYRAZOL-4-YL)-1-OXO-2,6-DIHYDRO-1H-[1,2]DIAZEPINO[4,5,6-CD]INDOL-8-YL)ACETAMIDE

#13263
20090312279
2009-12-17

Antimicrobial compositions

#13264
20090312273
2009-12-17

Compositions comprising dimethyl sulfoxide (DMSO)

#13265
20090312272
2009-12-17

Transglutaminase inhibitors and methods of use thereof

#13266
20090312259
2009-12-17

LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS

#13267
20090312253
2009-12-17

Methods of effecting Wnt signaling through Dkk structural analysis

#13268
20090312252
2009-12-17

Antimicrobial Activity in Variants of Lacritin

#13269
20090311351
2009-12-17

COMPOSITION CONTAINING A CEREAL MILLING PRODUCT

#13270
20090311350
2009-12-17

Compositions for alleviating inflammation and oxidative stress in a mammal

#13271
20090311347
2009-12-17

Combination therapy for bipolar disorder

#13272
20090311346
2009-12-17

METHOD FOR TREATING ACNE

#13273
20090311343
2009-12-17

Thiazole compounds, and compositions and methods using same

#13274
20090311342
2009-12-17

Method for activating and stabilizing dissolved hydrogen in water

#13275
20090311340
2009-12-17

USE OF XENON AS NEUROPROTECTANT IN A NEONATAL SUBJECT

#13276
20090311335
2009-12-17

COMBINATION OF A TRIPTAN AND AN NSAID

#13277
20090311334
2009-12-17

MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT

#13278
20090311312
2009-12-17

Transdermal hormone delivery system: compositions and methods

#13279
20090311281
2009-12-17

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

#13280
20090311277
2009-12-17

Nucleic acid compositions for stimulating immune responses

#13281
20090311274
2009-12-17

Nucleic acid encoding 238P1B2 useful in detecting cancer

#13282
20090311268
2009-12-17

Gene constructs coding for CD40-binding activating antibodies

#13283
20090311254
2009-12-17

CD40 ANTIBODY FORMULATION AND METHODS

#13284
20090311249
2009-12-17

Capecitabine Combination Therapy

#13285
20090311240
2009-12-17

VEGF165 Delivered by Fibrin Sealant to Reduce Tissue Necrosis

#13286
20090311238
2009-12-17

TOPICAL COMPOSITION AND TREATMENT METHOD FOR CARTILAGE DAMAGE

#13287
20090311237
2009-12-17

Combination therapy using a soluble hyaluronidase and a bisphosphonate

#13288
20090311236
2009-12-17

Therapeutic Peptide Compositions And Methods Of Making And Using Same

#13289
20090311232
2009-12-17

Agent for use in the case of fructose intolerance

#13290
20090311231
2009-12-17

PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM

#13291
20090311227
2009-12-17

Composition

#13292
20090311215
2009-12-17

Method for treating cervical cancer

#13293
20090311201
2009-12-17

Lipoxin analogs and methods for the treatment of periodontal disease

#13294
20090311175
2009-12-17

Methods for treating thyroid cancer

#13295
20090306679
2009-12-10

Method and apparatus for determining acetabular component positioning

#13296
20090306204
2009-12-10

Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association

#13297
20090306172
2009-12-10

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#13298
20090306160
2009-12-10

METHODS FOR IMPROVING DRUG DISPOSITION

#13299
20090306137
2009-12-10

TREATMENT FOR DEPRESSIVE DISORDERS

#13300
20090306119
2009-12-10

Non-Codeine Opioid Analgesic Process And Formulations

#13301
20090306104
2009-12-10

Use of Lck inhibitors for treatment of immunologic diseases

#13302
20090306101
2009-12-10

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

#13303
20090306098
2009-12-10

COMBINATION OF ROSCOVITINE AND A HDCA INHIBITOR TO TREAT PROLIFERATIVE DISEASES

#13304
20090306091
2009-12-10

ANTIMALARIAL THERAPY USING A COMBINATION OF SYNTHETIC ARTEMISININ DERIVATIVE AND BISQUINOLINE DERIVATIVE

#13305
20090306081
2009-12-10

Solid Dosage Formulations of Hydralazine Compounds and Nitric Oxide Donor Compounds

#13306
20090306051
2009-12-10

Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders

#13307
20090306040
2009-12-10

Mono and Combination Therapy of M1/M4 Agonist (Sabcomeline) for Treatment of Negative Symptoms of Schizophrenia

#13308
20090306037
2009-12-10

Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity

#13309
20090306034
2009-12-10

Use of picoplatin to treat colorectal cancer

#13310
20090306028
2009-12-10

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS

#13311
20090306027
2009-12-10

GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF THE GENETIC VARIATION OF G-PROTEIN BETA 3 SUBUNIT POLYMORPHISM

#13312
20090306026
2009-12-10

Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction

#13313
20090306025
2009-12-10

Method and composition for skin inflammation and discoloration

#13314
20090306024
2009-12-10

Combination preparations of o-acetylsalicylic acid salts

#13315
20090306023
2009-12-10

STABLE ORGANIC PEROXIDE COMPOSITIONS

#13316
20090306021
2009-12-10

Antimicrobial therapy for bacterial infections

#13317
20090306012
2009-12-10

THERAPEUTIC PROTOCOLS

#13318
20090305996
2009-12-10

USE OF NON-DIGESTABLE SACHARIDES FOR GIVING AN INFANT THE BEST START AFTER BIRTH

#13319
20090305993
2009-12-10

METHODS AND COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

#13320
20090305992
2009-12-10

USE OF AN INTERLEUKIN 1 RECEPTOR ANTAGONIST AND/OR PYRROLIDINEDITHIOCARBAMATE FOR THE TREATMENT OR PROPHYLAXIS OF TYPE 2 DIABETES

#13321
20090305985
2009-12-10

Immunomodulatory Agents For Treatment of Inflammatory Diseases

#13322
20090305980
2009-12-10

Methods and Compositions Related to TR4

#13323
20090305964
2009-12-10

PHARMACEUTICAL PREPARATIONS OF A GLP-1 MOLECULE AND AN ANTI-EMETIC DRUG

#13324
20090305963
2009-12-10

Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis

#13325
20090305956
2009-12-10

Treatment of Ras-expressing tumors

#13326
20090305953
2009-12-10

DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS

#13327
20090305398
2009-12-10

Recombinant double stranded RNA nucleocapsid and use of the same

#13328
20090304869
2009-12-10

Peptides Having an Ace Inhibiting Effect

#13329
20090304831
2009-12-10

Laxative Composition and Method

#13330
20090304827
2009-12-10

Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects

#13331
20090304826
2009-12-10

Method and composition for dermatoses

#13332
20090304825
2009-12-10

ESTROGENIC EXTRACTS FOR USE IN TREATING VAGINAL AND VULVAR ATROPHY

#13333
20090304821
2009-12-10

Pharmaceutical Combination

#13334
20090304820
2009-12-10

SOLUBILIZED BENZOYL PEROXIDE TOPICAL DRUG FORMULATION FOR THE TREATMENT OF ACNE

#13335
20090304819
2009-12-10

Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance

#13336
20090304816
2009-12-10

METHOD AND COMPOSITION FOR TREATING AND DIAGNOSING RESTLESS LEGS SYNDROME

#13337
20090304815
2009-12-10

Method of treatment for muscular dystrophy

#13338
20090304813
2009-12-10

VIRUCIDAL COMPOSITIONS AND USES

#13339
20090304811
2009-12-10

Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide

#13340
20090304805
2009-12-10

Combinations and modes of administration of therapeutic agents and combination therapy

#13341
20090304790
2009-12-10

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#13342
20090304789
2009-12-10

NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS

#13343
20090304785
2009-12-10

Escalating dosing regimen for effecting weight loss and treating obesity

#13344
20090304783
2009-12-10

COMPOSITIONS AND METHODS FOR TREATING BACTERIA

#13345
20090304781
2009-12-10

MASTER GENE OF ARTERIOGENESIS

#13346
20090304776
2009-12-10

TRANSMUCOSAL DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE THEREOF

#13347
20090304758
2009-12-10

Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields

#13348
20090304755
2009-12-10

PHARMACEUTICAL FORMULATION OF LOSARTAN

#13349
20090304747
2009-12-10

USE OF DMSO AND BOTULINUM TOXIN THERAPY FOR URINARY INCONTINENCE AND RELATED DISORDERS

#13350
20090304711
2009-12-10

Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 Antibodies

#13351
20090304707
2009-12-10

Monoclonal antibodies to basic fibroblast growth factor

#13352
20090304697
2009-12-10

Identification and use of prognostic and predictive markers in cancer treatment

#13353
20090304694
2009-12-10

Ang2 and Vegf Inhibitor Combinations

#13354
20090304688
2009-12-10

Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell Activators

#13355
20090304687
2009-12-10

METHODS OF USING CD40 BINDING AGENTS

#13356
20090304684
2009-12-10

METHODS AND COMPOSITIONS FOR NEEDLELESS DELIVERY OF ANTIBODIES

#13357
20090304675
2009-12-10

METHOD OF MODULATION OF MULLERIAN INHIBITORY SUBSTANCE (MIS) RECEPTOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#13358
20090304665
2009-12-10

Super fast-acting insulin compositions

#13359
20090304663
2009-12-10

USE OF GSK-3 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER

#13360
20090304655
2009-12-10

Infant formula with probiotics

#13361
20090304650
2009-12-10

Repair of the Bone Marrow Vasculature

#13362
20090304631
2009-12-10

HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR

#13363
20090304630
2009-12-10

Treating severe and acute viral infections

#13364
20090304628
2009-12-10

Stabilized pharmaceutical formulations that contain the interferons gammas and alpha in synergistic proportions

#13365
20090304626
2009-12-10

Hepatitis C virus inhibitors

#13366
20090304623
2009-12-10

Once A Day Formulation for Phosphate Binders

#13367
20090304615
2009-12-10

TRICYCLIC COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF

#13368
20090304608
2009-12-10

Aqueous Hydrogen Peroxide Solution for Use as a Disinfectant or Anti-Microbial Personal Care Product

#13369
20090304603
2009-12-10

TOPICAL STEROID SPRAY WITH BOTANIC SEED OILS

#13370
20090304602
2009-12-10

Nutritional supplement

#13371
20090300776
2009-12-03

COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION

#13372
20090299063
2009-12-03

Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor

#13373
20090298941
2009-12-03

Anti-adipocyte fatty acid-binding protein (AP2), anti-flap and anti-CySLT1 receptor herbal compositions

#13374
20090298929
2009-12-03

NOVEL NATURAL CYCLODEXTRIN COMPLEXES

#13375
20090298907
2009-12-03

Method for the preparation of 4-fluoro-α-[2-methyl-1-oxopropyl]-y-oxo-n-β-diphenylbenzenebutanamide and products therefrom

#13376
20090298875
2009-12-03

A Combination of Compounds, Which Can be Used in the Treatment of Respiratory Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma

#13377
20090298873
2009-12-03

Methods of screening for compounds that reduce microbial resistance to fluoroquinolones

#13378
20090298868
2009-12-03

QUINOLINE COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF

#13379
20090298852
2009-12-03

Pellet-form slow-release preparation for vertigo

#13380
20090298849
2009-12-03

Materials and Methods Relating to the Induction of Apoptosis in Target Cells

#13381
20090298818
2009-12-03

Pharmaceutical compounds

#13382
20090298817
2009-12-03

ANTI-AMNESIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

#13383
20090298802
2009-12-03

Pharmaceutical Compositions

#13384
20090298798
2009-12-03

Combinations of adapalene and benzoyl peroxide for treating acne lesions

#13385
20090298797
2009-12-03

COMBINATION THERAPY FOR THE TREATMENT OF INFLUENZA

#13386
20090298793
2009-12-03

Acylgycerophospholipids for treating symptoms concomitant with cancer

#13387
20090298791
2009-12-03

COMBINATIONS COMPRISING EPOTHILONES AND ANTIMETABOLITES

#13388
20090298790
2009-12-03

Therapeutic use for treating of leukemia

#13389
20090298789
2009-12-03

Organ arrest, protection and preservation

#13390
20090298752
2009-12-03

APLIDINE TREATMENT OF CANCERS

#13391
20090298749
2009-12-03

Dalbavancin compositions for treatment of bacterial infections

#13392
20090298748
2009-12-03

METHODS OF ADMINISTERING DALBAVANCIN FOR TREATMENT OF BACTERIAL INFECTIONS

#13393
20090298741
2009-12-03

Trophic factor combinations for nervous system treatment

#13394
20090297687
2009-12-03

Functional Food Having Positive Effects in the Prevention of Cardiovascular Diseases

#13395
20090297643
2009-12-03

BOTANICAL COMPOSITION AND ITS USES

#13396
20090297641
2009-12-03

Herbal compositions for the treatment of mucosal lesions

#13397
20090297640
2009-12-03

Nutritional composition for increasing creatine uptake in skeletal muscle

#13398
20090297639
2009-12-03

Cosmetic treatement method for fighting against skin ageing effects

#13399
20090297634
2009-12-03

Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof

#13400
20090297625
2009-12-03

AGENT FOR TREATING EYE DISEASES

#13401
20090297623
2009-12-03

Formulations, devices and methods for treating and preventing mucositis

#13402
20090297618
2009-12-03

COMPOSITION BENEFICIAL FOR VISUOGNOSIS PERSISTENCE AND USE THEREOF

#13403
20090297616
2009-12-03

Wound Care Composition

#13404
20090297611
2009-12-03

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A TYROSINE KINASE INHIBITOR, DELTA OPIOID RECEPTOR ANTAGONIST, NEUROKININ RECEPTOR ANTAGONIST, OR VCAM INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#13405
20090297610
2009-12-03

Composition and system to promote wound healing

#13406
20090297600
2009-12-03

Pharmaceutical formulation containing a biguanide and an angiotensin antagonist

#13407
20090297598
2009-12-03

THERAPEUTIC COMBINATION

#13408
20090297576
2009-12-03

Local Delivery of PAR-1 Antagonists to Treat Vascular Complications

#13409
20090297573
2009-12-03

Identifying and modulating molecular pathways that mediate nervous system plasticity

#13410
20090297537
2009-12-03

Methods for identifying a GLP-1 secretagogue

#13411
20090297529
2009-12-03

ANTI-FLT3 ANTIBODIES

#13412
20090297519
2009-12-03

ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272

#13413
20090297517
2009-12-03

METHODS FOR TREATING IL-18 MEDIATED DISORDERS

#13414
20090297511
2009-12-03

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#13415
20090297510
2009-12-03

INHIBITION OF CALPAIN REDUCES ALLERGIC INFLAMMATION

#13416
20090297499
2009-12-03

USE OF CHARCOAL FOR TREATING INFLAMMATORY CONDITIONS

#13417
20090297497
2009-12-03

Methods and compositions for treating nephrogenic diabetes and insipidus

#13418
20090297496
2009-12-03

Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases

#13419
20090297491
2009-12-03

Compositions containing non-polar compounds

#13420
20090297490
2009-12-03

Human T-cell population

#13421
20090297477
2009-12-03

Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders

#13422
20090297475
2009-12-03

CYSTEINE DIOXYGENASE POLYMORPHISMS

#13423
20090297472
2009-12-03

Hepatitis C virus inhibitors

#13424
20090297471
2009-12-03

Methods For Autologous Stem Cell Transplantation

#13425
20090297470
2009-12-03

Remedies for ischemia

#13426
20090292237
2009-11-26

Modular drug delivery system for minimizing trauma during and after insertion of a cochlear lead

#13427
20090292021
2009-11-26

ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS

#13428
20090291995
2009-11-26

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#13429
20090291980
2009-11-26

Triglyceride-lowering agent and hyperinsulinism-ameliorating agent

#13430
20090291975
2009-11-26

DUAL OPIOID PAIN THERAPY

#13431
20090291964
2009-11-26

Potentiators of Antibacterial Activity

#13432
20090291961
2009-11-26

COMBINATION OF AN MEK INHIBITOR AND THE SRC KINASE INHIBITOR AZD0530 FOR USE IN THE TREATMENT OF CANCER

#13433
20090291952
2009-11-26

Modulators of pharmacokinetic properties of therapeutics

#13434
20090291950
2009-11-26

BICYCLIC HETEROARYL INHIBITORS OF PDE4

#13435
20090291939
2009-11-26

Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking

#13436
20090291931
2009-11-26

Compositions with enhanced elasticizing activity

#13437
20090291927
2009-11-26

Extended cycle multiphasic oral contraceptive kit

#13438
20090291910
2009-11-26

AGENT AND FOOD FOR PREVENTING/IMPROVING FUNCTIONAL DIGESTIVE DISORDER

#13439
20090291909
2009-11-26

AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE

#13440
20090291908
2009-11-26

Use of thiophoshonoformic acid and nrtis to treat viral infections

#13441
20090291900
2009-11-26

Methods for treatment of headaches by administration of oxytocin

#13442
20090291894
2009-11-26

METHODS FOR TREATING PROGRESSIVE COGNITIVE DISORDERS RELATED TO NEUROFIBRILLARY TANGLES

#13443
20090291884
2009-11-26

Proteins for use in diagnosing and treating infection and disease

#13444
20090291883
2009-11-26

COMBINATION OF AN IMMUNOSUPPRESSIVE AGENT AND NONSTEROIDAL ANTI -INFLAMMATORY DRUGS TO TREAT DISEASE

#13445
20090291877
2009-11-26

TREATMENTS USING CITRULLINE

#13446
20090291154
2009-11-26

Herbal extract pharmaceutical composition and method for treating and/or preventing of hyperlipidemia and processes for producing the same

#13447
20090291151
2009-11-26

Reduced weight decontamination formulation utilizing a solid peracid compound for neutralization of chemical and biological warfare agents

#13448
20090291143
2009-11-26

Combination of azelastine and mometasone for nasal administration

#13449
20090291128
2009-11-26

Transdermal delivery of cannabidiol

#13450
20090291123
2009-11-26

Opioid Combination Wafer

#13451
20090291122
2009-11-26

Wound Care Treatment Product

#13452
20090291114
2009-11-26

OSTEOGENIC COMPOSITION COMPRISING A GROWTH FACTOR/AMPHIPHILIC POLYMER COMPLEX, A SOLUBLE CATION SALT AND AN ORGANIC SUPPORT

#13453
20090291102
2009-11-26

Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof

#13454
20090291091
2009-11-26

USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES

#13455
20090291085
2009-11-26

Antibodies against ErbB3 and uses thereof

#13456
20090291084
2009-11-26

Anti-IL-6 antibodies, compositions, methods and uses

#13457
20090291075
2009-11-26

BINDING AGENTS AND THEIR USE IN TARGETING TUMOR CELLS

#13458
20090291073
2009-11-26

Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same

#13459
20090291061
2009-11-26

STEM CELL THERAPY FOR BLOOD VESSEL DEGENERATION

#13460
20090291060
2009-11-26

Treatment of HIV

#13461
20090291047
2009-11-26

Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer

#13462
20090288611
2009-11-26

Formula and method for treating water in fish tanks

#13463
20090286986
2009-11-19

Isoindole-imide compounds, compositions, and uses thereof

#13464
20090286884
2009-11-19

Hops Beta-Acid Anti-Diabetic Composition

#13465
20090286881
2009-11-19

SELECTED BETAINES AND THEIR USES

#13466
20090286879
2009-11-19

Preventive or Therapeutic Drug for Alzheimer-Type Dementia

#13467
20090286872
2009-11-19

Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties

#13468
20090286871
2009-11-19

Use of a plant oil product as an agent for increasing the synthesis of skin lipids

#13469
20090286870
2009-11-19

Cancer treatment using FTS and 2-deoxyglucose

#13470
20090286850
2009-11-19

Inhibition of EMT induction in tumor cells by anti-cancer agents

#13471
20090286831
2009-11-19

VR1 Receptor Ligands and u-Opioid Receptor Ligands for the Treatment of Pain

#13472
20090286822
2009-11-19

Treatment of psoriasis and of other skin disorders associated with inhibition of differentiation of epidermal cells

#13473
20090286795
2009-11-19

USE OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITORS FOR THE TREATMENT OF CANCER

#13474
20090286769
2009-11-19

Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

#13475
20090286762
2009-11-19

Pharmaceutical Formulations Comprising Azelastine and a Corticosteroid for the Treatment of Inflammatory or Allergic Conditions

#13476
20090286761
2009-11-19

Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device

#13477
20090286760
2009-11-19

Compositions and methods for treating hyperproliferative diseases

#13478
20090286743
2009-11-19

Methods and Compositions for Treating Conditions of the Eye

#13479
20090286731
2009-11-19

METHODS AND COMPOSITIONS FOR THE TREATMENT OF XEROSTOMIA

#13480
20090286490
2009-11-19

OSCILLATOR CIRCUIT, TRANSCEIVER, AND METHOD FOR GENERATING OSCILLATORY SIGNAL

#13481
20090285917
2009-11-19

COMPOSITION COMPRISING COMPLEX CRUDE DRUG EXTRACTS SHOWING ANTI-ALLERGIC RHINITIS, ANTI-ATOPIC DERMATITIS AND ANTI-ASTHMA ACTIVITY

#13482
20090285915
2009-11-19

Synergistic pharmaceutical composition, method of making same and use of same

#13483
20090285914
2009-11-19

Composition comprising thunb. extract, blume extract, or herbal mixture extract thereof

#13484
20090285912
2009-11-19

Food Supplement and Method for Enhancing Athletic Performance

#13485
20090285911
2009-11-19

Cynara scolymus extracts, the use thereof and formulations containing them

#13486
20090285900
2009-11-19

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A BETA-AGONIST BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#13487
20090285899
2009-11-19

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A METHYLXANTHINE DERIVATIVE FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#13488
20090285898
2009-11-19

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTICHOLINERGIC BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#13489
20090285890
2009-11-19

Antimicrobial peroxidase compositions

#13490
20090285849
2009-11-19

Thiosemicarbazones as anti-virals and immunopotentiators

#13491
20090285841
2009-11-19

Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

#13492
20090285834
2009-11-19

NOVEL MEMORY CTL INDUCTION POTENTIATOR

#13493
20090285832
2009-11-19

IL-8 as a biomarker for sunitinib resistance

#13494
20090285826
2009-11-19

COMBINATION DRUGS COMPRISING VEGF INHIBITOR AND SERINE PROTEASES/THROMBOLYTIC COMPOUNDS FOR TREATING NEOVASCULAR DISORDERS

#13495
20090285817
2009-11-19

Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene

#13496
20090285814
2009-11-19

CD 40 Binding Molecules and CTL Pepetides for Treating Tumors

#13497
20090285802
2009-11-19

Highly concentrated stabilized IgM solution

#13498
20090285794
2009-11-19

Fermented cereal product obtained by fermentation of rye bran with a Lactobacillus curvatus strain

#13499
20090285792
2009-11-19

Compositions and methods for treatment of neovascular diseases

#13500
20090285790
2009-11-19

Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders